ProShares Ultra Bloomberg Natural Gas ETF vs Nuwellis Inc — how do they compare? ProShares Ultra Bloomberg Natural Gas ETF trades at $20.81, while Nuwellis Inc trades at $1.41 (market cap $542.80K). Which is the better fit depends on your goals.
| BOIL | NUWE | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $87.24 | $220.50 |
52-Week Low | $18.74 | $1.42 |
Market Cap | — | $542.80K |
Enterprise Value | — | -$1.27M |
Signals from Pluang's Aura AI — not financial advice
BOIL trades at $21.085, up 1.81% in the last 24 hours, with a bearish technical signal from moving averages and neutral oscillators. Recent news highlights U.S. natural gas futures stability amid weather-driven demand shifts. The company, Beyond Oil Ltd., focuses on food-tech innovations to reduce health risks in fried foods, with recent corporate actions including a 1:2 stock split effective May 28, 2026.
The outlook for BOIL is cautious due to bearish technical trends and reliance on natural gas market volatility. Investment opportunities hinge on energy sector demand and company-specific growth in food-tech, while risks include commodity price swings and execution challenges in scaling innovations.
NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.
Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.
Trailing returns across standard periods
BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →